Determination of Human Cytomegalovirus Pp65 Antigenemia Among Renal Transplant Patients

Overview

Journal Indian J Nephrol

Specialty Nephrology

Date 2013 Jan 18

PMID 23326044

Authors

S Moses

J Malathi

N R Singha

R Bagyalakshmi

H N Madhavan

Affiliations

Soon will be listed here.

Abstract

Human cytomegalovirus (HCMV) is an important cause of morbidity and mortality in immunosuppressed transplant recipients. Isolation of HCMV from peripheral blood leukocytes (PBLs) is considered a reliable marker of disseminated HCMV infection. HCMV pp65 antigenemia is widely used for monitoring CMV infection and guiding preemptive therapy. The aim of this study was to compare pp65 antigenemia with culture technique for detection of HCMV in PBLs among kidney transplant patients and also to determine the threshold value of significant pp65 antigenemiat. Fifty-one peripheral blood samples from post-renal transplant patients collected during August 2009 to March 2011 were processed for pp65 antigenemia assay. These were also tested for isolation of the virus by inoculation into human corneal fibroblast cells. The results of pp65 antigenemia and culture were compared to determine the clinical significance of pp65 antigenemia. HCMV was isolated in 21 cases. On comparing the pp65 antigenemia results with that of the viral isolation, a mean of 23 cells was determined to yield a positive isolation of HCMV. The values of pp65 antigenemia and isolation results were correlated (paired t-test, P = 0.0029). A pp65 count of 23 and above was considered significant in our clinical settings since we found that these clinical specimens yield positive culture result.

References

Boeckh M, Boivin G . Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev. 1998; 11(3):533-54. PMC: 88895. DOI: 10.1128/CMR.11.3.533. View

Patel R, Paya C . Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997; 10(1):86-124. PMC: 172945. DOI: 10.1128/CMR.10.1.86. View

Saltzman R, Quirk M, Jordan M . Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest. 1988; 81(1):75-81. PMC: 442475. DOI: 10.1172/JCI113313. View

Storch G, Buller R, Bailey T, Ettinger N, Langlois T, Gaudreault-Keener M . Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol. 1994; 32(4):997-1003. PMC: 267169. DOI: 10.1128/jcm.32.4.997-1003.1994. View

Mussi-Pinhata M, Yamamoto A, Moura Brito R, Isaac M, de Carvalho e Oliveira P, Boppana S . Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis. 2009; 49(4):522-8. PMC: 2778219. DOI: 10.1086/600882. View

Reed E, Bowden R, Dandliker P, Lilleby K, Meyers J . Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med. 1988; 109(10):783-8. DOI: 10.7326/0003-4819-109-10-783. View

van Son W, The T . Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transpl Int. 1989; 2(3):147-64. DOI: 10.1007/BF02414602. View

Mazzulli T, Drew L, Yen-Lieberman B, Jekic-McMullen D, Kohn D, Isada C . Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol. 1999; 37(4):958-63. PMC: 88632. DOI: 10.1128/JCM.37.4.958-963.1999. View

Madhavan H, Samson M, Ishwarya M, Vijayakumar R, Jambulingam M . "pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies". Virol J. 2010; 7:322. PMC: 2998481. DOI: 10.1186/1743-422X-7-322. View

10.

Schroeder R, Michelon T, Fagundes I, Bortolotto A, Lammerhirt E, Oliveira J . Antigenemia for cytomegalovirus in renal transplantation: choosing a cutoff for the diagnosis criteria in cytomegalovirus disease. Transplant Proc. 2005; 37(6):2781-3. DOI: 10.1016/j.transproceed.2005.06.091. View

11.

Cariani E, Pollara C, Valloncini B, Perandin F, Bonfanti C, Manca N . Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients. BMC Infect Dis. 2007; 7:138. PMC: 2222614. DOI: 10.1186/1471-2334-7-138. View

12.

PANDE H, Forman S, Tanamachi B, Li C, Zaia J, Greenberg P . Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol. 1994; 43(1):103-10. DOI: 10.1002/jmv.1890430119. View

13.

Garnett H . Isolation of human cytomegalovirus from peripheral blood T cells of renal transplant patients. J Lab Clin Med. 1982; 99(1):92-7. View

14.

Jacobson M, Mills J . Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med. 1988; 108(4):585-94. DOI: 10.7326/0003-4819-108-4-585. View

15.

Meyers J, Flournoy N, Thomas E . Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis. 1986; 153(3):478-88. DOI: 10.1093/infdis/153.3.478. View

16.

Fiala M, Payne J, Berne T, Moore T, Henle W, Montgomerie J . Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis. 1975; 132(4):421-33. DOI: 10.1093/infdis/132.4.421. View

17.

Ljungman P, De Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J . Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant. 1993; 12(4):399-403. View

18.

Meyers J, Ljungman P, Fisher L . Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis. 1990; 162(2):373-80. DOI: 10.1093/infdis/162.2.373. View

19.

Prentice H, Kho P . Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant. Bone Marrow Transplant. 1997; 19(2):135-42. DOI: 10.1038/sj.bmt.1700630. View

20.

Gerna G, Percivalle E, Sarasini A, Revello M . Human cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation. J Clin Microbiol. 2002; 40(1):233-8. PMC: 120119. DOI: 10.1128/JCM.40.1.233-238.2002. View